Abstract
Natasa Blagojevic-Stokic, Paul Whiteley, Ben Marlow, Jane Wills
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2013
Risk of autoimmune disease in research-identified cases of autism spectrum disorder: a longitudinal, population-based birth cohort study
10.1097/dbp.0000000000001232 · 2024
Association between autism spectrum disorder and inflammatory bowel disease: a systematic review and meta-analysis
10.1002/aur.2656 · 2022
Autism spectrum disorder and epilepsy
10.1016/j.ncl.2022.03.011 · 2022
Autism spectrum disorder and schizophrenia: an updated conceptual review
10.1002/aur.2659 · 2022
Autism and depression are connected: a report of two complimentary network studies
10.1177/1362361319872373 · 2020
The co-occurrence of autistic spectrum disorder and schizophrenia: a nationwide population-based study
10.1016/j.jpsychires.2021.04.012 · 2021
Occurrence of psychosis and bipolar disorder in adults with autism: a systematic review and meta-analysis
10.1016/j.neubiorev.2022.104543 · 2022
Prevalence of dementia among US adults with autism spectrum disorder
10.1001/jamanetworkopen.2024.53691 · 2025
Risk of Parkinson disease in individuals with autism spectrum disorder
10.1001/jamaneurol.2025.1284 · 2025
Neurodevelopmental hypothesis about the etiology of autism spectrum disorders
10.3389/fnhum.2017.00354 · 2017
Autism spectrum disorder symptoms are associated with connectivity between large-scale neural networks and brain regions involved in social processing
10.1007/s10803-020-04383-w · 2020
Energy metabolism in childhood neurodevelopmental disorders
2021
Astrocyte-derived ATP: a new etiological factor for autism spectrum disorder
10.1007/s12264-021-00788-4 · 2022
Metabolic dynamics in astrocytes and microglia during post-natal development and their implications for autism spectrum disorders
10.3389/fncel.2024.1354259 · 2024
Mini-review: brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism
10.1016/j.neulet.2021.136003 · 2021
Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders
10.1016/j.neubiorev.2022.104892 · 2022
Involvement of brain metabolism in neurodevelopmental disorders
10.1016/bs.irn.2023.08.004 · 2023
Brain power
10.1073/pnas.2107022118 · 2021
The brain selectively allocates energy to functional brain networks under cognitive control
10.1038/s41598-024-83696-7 · 2024
Attention and capacity limits in perception: a cellular metabolism account
10.1523/jneurosci.2368-19.2020 · 2020
The control costs of human brain dynamics
10.1162/netn_a_00425 · 2025
Cognitive cost as dynamic allocation of energetic resources
10.3389/fnins.2015.00289 · 2015
An energy costly architecture of neuromodulators for human brain evolution and cognition
10.1126/sciadv.adi7632 · 2023
Correspondence between cerebral glucose metabolism and BOLD reveals relative power and cost in human brain
10.1038/s41467-019-08546-x · 2019
Control of brain energy supply by astrocytes
10.1016/j.conb.2017.09.012 · 2017
Brain energy homeostasis: the evolution of the astrocyte-neuron lactate shuttle hypothesis
10.4196/kjpp.24.388 · 2025
Glucose sparing by glycogenolysis (GSG) determines the relationship between brain metabolism and neurotransmission
10.1177/0271678x211064399 · 2022
Astrocytes drive divergent metabolic gene expression in humans and chimpanzees
10.1093/gbe/evad239 · 2024
Molecular signature of primate astrocytes reveals pathways and regulatory changes contributing to human brain evolution
10.1016/j.stem.2024.12.011 · 2025
Comparative analysis of astrocytes in the prefrontal cortex of primates: insights into the evolution of human brain energetics
10.1002/cne.25387 · 2022
Astrocytic glycolysis attenuates mitochondrial efficiency to preserve cognition
2025
The role of astrocyte-mediated plasticity in neural circuit development and function
10.1186/s13064-020-00151-9 · 2021
Brain stars take the lead during critical periods of early postnatal brain development: relevance of astrocytes in health and mental disorders
10.1038/s41380-024-02534-4 · 2024
From synapses to circuits, astrocytes regulate behavior
2022
Developmental neural activity requires neuron–astrocyte interactions
10.1002/dneu.22870 · 2022
Adenosine and astrocytes determine the developmental dynamics of spike timing-dependent plasticity in the somatosensory cortex
10.1523/jneurosci.0115-22.2022 · 2022
Energetic substrate availability regulates synchronous activity in an excitatory neural network
10.1371/journal.pone.0220937 · 2019
The effects of early-life iron deficiency on brain energy metabolism
10.1177/2633105520935104 · 2020
Aberrant “deep connectivity” in autism: a cortico–subcortical functional connectivity magnetic resonance imaging study
10.1002/aur.2058 · 2019
Canagliflozin alleviates valproic acid-induced autism in rat pups: role of PTEN/PDK/PPAR-γ signaling pathways
10.3389/fphar.2023.1113966 · doi-reference
Repurposing SGLT2 inhibitors for neurological disorders: a focus on the autism spectrum disorder
10.3390/molecules27217174 · doi-reference
A pilot dose finding study of pioglitazone in autistic children
10.1186/s13229-018-0241-5 · doi-reference
Effect of pioglitazone treatment on behavioral symptoms in autistic children
10.1186/1742-2094-4-3 · doi-reference
Insulin receptor sensitization restores neocortical excitation/inhibition balance in a mouse model of autism
10.1186/s13229-018-0196-6 · doi-reference
Microglia and astrocyte activation by toll-like receptor ligands: modulation by PPAR-γ agonists
10.1155/2008/453120 · doi-reference
Peroxisome proliferator-activated receptor γ thiazolidinedione agonists increase glucose metabolism in astrocytes
10.1074/jbc.m208132200 · doi-reference
Metformin as targeted treatment in fragile X syndrome
10.1111/cge.13039 · doi-reference
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: mechanistic study of risperidone and metformin monotherapy versus combination
10.1016/j.pnpbp.2022.110522 · doi-reference
Metformin administration during early postnatal life rescues autistic-like behaviors in the BTBR T+ Itpr3tf/J mouse model of autism
10.3389/fnbeh.2018.00290 · doi-reference
Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial
10.1177/02698811241303593 · doi-reference
Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial
10.1038/ejhg.2016.109 · doi-reference
A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome
10.1186/2040-2392-5-54 · doi-reference
Intranasal insulin eases autism in rats via GDF-15 and anti-inflammatory pathways
10.3390/cimb46090624 · doi-reference
Intranasal insulin alleviates traumatic brain injury by inhibiting autophagy and endoplasmic reticulum stress-mediated apoptosis through the PI3K/Akt/mTOR signaling pathway
10.1016/j.neuroscience.2023.08.009 · doi-reference
Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin
10.1002/jnr.21787 · doi-reference
Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans
10.2337/db12-0025 · doi-reference
Hot spots for the use of intranasal insulin: cerebral ischemia, brain injury, diabetes mellitus, endocrine disorders and postoperative delirium
10.3390/ijms24043278 · doi-reference
Central effects of acute intranasal insulin on neuroimaging, cognitive, and behavioural outcomes: a systematic review
10.1016/j.neubiorev.2024.105907 · doi-reference
Effects of folic acid supplementation in pregnant mice on glucose metabolism disorders in male offspring induced by lipopolysaccharide exposure during pregnancy
10.1038/s41598-023-31690-w · doi-reference
High-dose leucovorin reverses acute high-dose methotrexate neurotoxicity in the rat
10.1002/ana.410250408 · doi-reference
Sugar as a therapeutic target for the cognitive restoration following traumatic brain injury
10.1097/wco.0000000000000752 · doi-reference
Folic acid deficiency increases sensitivity to DNA damage by glucose and methylglyoxal
10.1093/mutage/geac003 · doi-reference
Population pharmacokinetic and pharmacodynamic model guided weight-tiered dose of AST-001 in pediatric patients with autism spectrum disorder
10.3389/fphar.2024.1452526 · doi-reference
A clinical study of urine amino acids in children with autism spectrum disorder
10.3390/life14050629 · doi-reference
L-serine: a neglected amino acid with a potential therapeutic role in diabetes
10.1111/apm.12987 · doi-reference
l-serine links metabolism with neurotransmission
10.1016/j.pneurobio.2020.101896 · doi-reference
Metabolic and functional effects of beta-hydroxy-beta-methylbutyrate (HMB) supplementation in skeletal muscle
10.1007/s00421-011-2224-5 · doi-reference
Effects of β-hydroxy β-methylbutyrate supplementation on working memory and hippocampal long-term potentiation in rodents
10.3390/nu14051090 · doi-reference
Suppression of experimental autoimmune encephalomyelitis in mice by β-hydroxy β-methylbutyrate, a body-building supplement in humans
10.4049/jimmunol.2200267 · doi-reference
Muscle-building supplement β-hydroxy β-methylbutyrate binds to PPARα to improve hippocampal functions in mice
10.1016/j.celrep.2023.112717 · doi-reference
Potent anti-seizure effects of D-leucine
10.1016/j.nbd.2015.05.013 · doi-reference
Metabolic and regulatory roles of leucine in neural cells
10.1007/s11064-007-9444-4 · doi-reference
Generation of ketone bodies from leucine by cultured astroglial cells
10.1046/j.1471-4159.1995.65062450.x · doi-reference
Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American college of medical genetics and genomics
10.1038/gim.2016.203 · doi-reference
Creatine deficiency syndromes
10.1016/b978-0-444-59565-2.00053-8 · doi-reference
Potential of creatine in glucose management and diabetes
10.3390/nu13020570 · doi-reference
Potential role of creatine as an anticonvulsant agent: evidence from preclinical studies
10.3389/fnins.2023.1201971 · doi-reference
“Heads up” for creatine supplementation and its potential applications for brain health and function
10.1007/s40279-023-01870-9 · doi-reference
Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof
10.3389/fncel.2018.00274 · doi-reference